Spots Global Cancer Trial Database for prostate cancer with at least one bone lesion in patients receiving hormonal therapy and treatment with bisphosphonates is indicated
Every month we try and update this database with for prostate cancer with at least one bone lesion in patients receiving hormonal therapy and treatment with bisphosphonates is indicated cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates | NCT00172016 | Prostate Cancer... | Zoledronic acid | 18 Years - | Novartis | |
| A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates | NCT00172016 | Prostate Cancer... | Zoledronic acid | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
